Middle East & Africa AI-Assisted Medical Imaging Market 2025-2032: ~24% CAGR Predicted Through 2032

(MENAFN- GlobeNewsWire - Nasdaq) The MEA market offers growth in AI within healthcare, with the GCC leading investment, focusing on enterprise AI suites. Key opportunities include shifts in imaging modalities, growth in software/services, and cloud options in Africa. Regional strategies and scalable solutions are crucial for success.

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Middle East & Africa AI-assisted Medical Imaging Market 2025-2032" has been added to ResearchAndMarkets's offering.

In a significant development for the Middle East and Africa (MEA) healthcare technology landscape, the region is set to witness a massive growth trajectory with healthcare investments projected to rise from approximately US$25 million in 2023 to around US$500 million by 2032. This represents an impressive compound annual growth rate (CAGR) of about 24%.

The Gulf Cooperation Council (GCC) countries, including Saudi Arabia, UAE, Qatar, Kuwait, Oman, and Bahrain, are expected to account for over 60% of this expenditure, primarily driven by enterprise AI suite adoption. Sub-Saharan Africa will focus on scaling low-bandwidth digital radiology and ultrasound AI through operational expenditure models and teleradiology services.

This strategic insight translates evidence into actionable strategies detailing where to compete and how to succeed across different countries, healthcare modalities, and buyer segments. The transformation in the region's healthcare technology market is marked by shifts such as:

• Size & Pace: Advancing from an estimated US$25M in 2023 to approximately US$500M by 2032, marking a ~24% CAGR.
• GCC Dominance: More than 60% of the region's investment will be centralized in GCC nations, focusing heavily on established healthcare systems.
• Modality Market Shift: By 2032, CT usage is expected to decline from 36% to 23%, while MRI will increase from 32% to 39%, and X-ray/Digital Radiography (DR) from 16% to 22%.
• Clinical Focus: Oncology, cardiology, and stroke treatments are identified as the primary contributors to growth in healthcare technology adoption.
• Revenue Stream Evolution: Future growth will be driven by declining hardware reliance, with software and service adoption rising, and significant expansion in cloud-based and pay-per-use models, particularly across Africa.

For buyers, the region-specific playbooks offer concrete advantages through action plans, partner networks, and pricing strategies tailored to the GCC, North Africa, and Sub-Saharan markets. These guides provide valuable insights into bundling strategies for CT/MR packages versus DR/ultrasound operational expenditure options, including procurement and hosting checklists prioritizing regional specifics like Arabic user interfaces and data residency for the GCC, and offline capabilities for African contexts. Moreover, evidential alignment with budget considerations, such as time-to-treatment and cost-effectiveness, is essential for securing enterprise-level approvals, supported by an evidence-based go-to-market framework driven by growth and maturity, ecosystem collaboration, and solution adoption.

Methodology & Quality Assurance: The dual-lens approach integrates top-down projections aligned with global trends and a bottom-up engine evaluating shipment patterns and average selling prices. Distinct regional weightings involve regulatory signaling and partnership patterns, maintaining a high level of accuracy with discrepancies kept to 0.5% or less. A comprehensive quality assurance loop ensures the data's freshness, regulatory compliance, and accuracy in price assessments.

Key Topics Covered:

SECTION 1 - EXECUTIVE SUMMARY

• The 25-second read
• Size & Pace (where dollars concentrate)
• Modality Mix (MEA, 2023-2032)
• Clinical pathways (MEA, 2023-2032)
• Revenue Stream Dynamics
• Country/Cluster Snapshots
• 12-month actions (MEA "Pulse Quick-wins")

SECTION 2 - RESEARCH METHODOLOGY

• Scope & Segmentation
• Dual-Lens Architecture
• MEA-Specific Inputs & Weighting
• Assumptions & calibration choices (MEA)
• Quality assurance (standard Pulse QA)
• Limitations & Mitigations

SECTION 3 - MARKET OVERVEW & ANALYSIS - MEA

• MEA Market Snapshot
• Logical Clusters & Why They Matter
• Key Growth Catalysts
• Structural Barriers & Mitigation
• Actionable Recommendations by Vendor Type
• Sequencing Roadmap
• Executive Takeaways

SECTION 4 - MARKET ESTIMATES & FORECASTS - MEA

• MEA Market by Clinical Area (2023-2032)
• Growth Drivers & Restraints
• MEA Market by Modality (2023-2032)
• Modality Share Shifts
• MEA Market by Revenue Stream (2023-2032)
• Revenue Stream Shifts & Strategic Implications
• MEA Market by Clinical Application (2023-2032)
• Clinical Application Shifts & Takeaways
• MEA Market by End-Use Organization (2023-2032)
• End-User Adoption Patterns
• MEA Market by AI Technology (2023-2032)
• Technology Shifts and Takeaways

SECTION 5 - MARKINTEL SOLUTION ADOPTION & GROWTH MATRIX - MEA

• Interpretation & Operating Roadmap
• Execution Checklist

SECTION 6 - MARKINTEL ECOSTSYSTEM COLLABORATION MATRIX - MEA

• Partnership Playbook
• Operating Roadmap & Key Execution Metrics

SECTION 7 - GTM AT-A-GLANCE (MEA)

• GTM Readiness Radar - MEA
• Country Cluster Heatmap - MEA
• GTM Timeline - Pilot to Scale (2024-2029) - MEA
• Adjacency-Opportunity Radar - MEA
• GTM Maturity Highlights - MEA
• Regulatory Velocity - MEA
• Attach Rate Trends - MEA

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN01102025004107003653ID1110134569